Search | TVST | ARVO Journals

Showing 1 – 20 of 166

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract June 2024

Evaluating the distribution of fundus autofluorescence phenotypes in a large, European intermediate AMD cohort and describing a novel phenotype (A PINNACLE Study Report)

Tom Taylor; Rebecca Anne Kaye; Julia Mai; Lars Fritsche; Toby Prevost; Daniel Rueckert; Hrvoje Bogunovic; Hendrik P Scholl; Ursula Schmidt-Erfurth; Sobha Sivaprasad; Andrew Lotery

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):2266.

ARVO Annual Meeting Abstract June 2024

Evaluating Retinal Sensitivity Losses on Microperimetry in Diabetic Macular Ischemia – One Year Result

Wei-Shan Tsai; Sridevi Thottarath; Sarega Gurudas; Liz Pearce; Andrea Giani; Taffeta Yamaguchi; Jinzhi Zhao; Gemmy Cheung; Sobha Sivaprasad

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):6350.

ARVO Annual Meeting Abstract June 2024

Intersession repeatability and annual changes in optical coherence tomography angiography (OCTA) metrics and visual function in diabetic macular ischaemia

Sridevi Thottarath; Wei-Shan Tsai; Sarega Gurudas; Jinzhi Zhao; Liz Pearce; Taffeta Ching Ning Yamaguchi; Gemmy Cheung; Sobha Sivaprasad

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):5518.

ARVO Annual Meeting Abstract June 2024

Prevalence and Risk Factors of Type 2 Diabetes Mellitus and Diabetic Retinopathy among People Living with HIV in South India

Rajiv Raman; Keerthana Raghu; Sudharshan Sridharan; Janani surya; Sobha Sivaprasad

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):1786.

ARVO Annual Meeting Abstract June 2024

An interpretable deep learning model for detection of referable/non-referable diabetic retinopathy: a retrospective, multicenter study

Xiaoyan Hu; Anran Ran; Gabriel YANG; Truong Xuan Nguyen; Sobha Sivaprasad; Gavin S Tan; Simon Szeto; Carol Cheung

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):1597.

ARVO Annual Meeting Abstract June 2024

Patient-tailored Microperimetry Grids for Focal Lesions in Intermediate AMD: A PINNACLE Study Report

Stefan Futterknecht; Maximilian Pfau; Philipp Anders; Julia Mai; Ursula Hall; Hrvoje Bogunovic; Lars Fritsche; Daniel Rueckert; Ursula Schmidt-Erfurth; Sobha Sivaprasad; Andrew Lotery; Hendrik P Scholl

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):4386.

ARVO Annual Meeting Abstract June 2024

Promoting ophthalmic research in underserved communities.

Roxanne Crosby-Nwaobi; Subhash Suthar; Yvonne Shek; Sarah Valentine; Helen Baker; Helen Khan; Nicola Dunlop; Tendai Gwenhure; Grace Eni; Nafeesa Reece; Charlene Formento; Rukhiya Bana; Sobha Sivaprasad

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):2157.

ARVO Annual Meeting Abstract June 2024

Real-world outcomes of faricimab injections in treatment-naïve neovascular age-related macular degeneration (nAMD) patients: The Moorfields Experience

Sing Yue Sim; Luke Nicholson; Praveen J Patel; Bhairavi Bhatia; Evangelia Chalkiadaki; Georgios Koutsocheras; Senthil Selvam; Sobha Sivaprasad; Bishwanath Pal; Pearse Andrew Keane; Robin Hamilton

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):246.

ARVO Annual Meeting Abstract June 2024

A 96-week PULSAR subgroup analysis: Similar visual and anatomic improvements with aflibercept 8 mg every 12 weeks or longer and 2 mg every 8 weeks, as defined by baseline BCVA, CRT, CNV type, and race

Richard Gale; Oliver Zeitz; Sobha Sivaprasad; Sergio Leal; Tobias Machewitz; xin Zhang

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):4906.

ARVO Annual Meeting Abstract June 2024

Validation of polygenic risk score in age-related macular degeneration prognosis: a pilot study

Yiu Wai Chan; Timing Liu; Ismail Moghul; Siegfried Wagner; Dun Jack Fu; Alan Sousa da Silva; Gongyu Zhang; Gunjan Naik; Pallavi Bagga; Sophie Glinton; Sobha Sivaprasad; Anthony P Khawaja; Praveen J Patel; Pearse Andrew Keane; Nikolas Pontikos; Konstantinos Balaskas

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):5648.

ARVO Annual Meeting Abstract June 2024

Comparative analysis of anatomical and visual parameters in treatment-resistant neovascular age related macular degeneration (nAMD) patients pre- and post-switch to faricimab: A Moorfields Analysis

Georgios Koutsocheras; Evangelia Chalkiadaki; Sing Yue Sim; Senthil Selvam; Bhairavi Bhatia; Sobha Sivaprasad; Bishwanath Pal; Pearse Andrew Keane; Luke Nicholson; Robin Hamilton; Praveen J Patel

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):4316.

ARVO Annual Meeting Abstract June 2024

Using adaptive optics to assess hyporeflective clumps as a biomarker for progression to cRORA in the PINNACLE study

Christopher Holmes; Naomi Wijesingha; Syed Ahmer Raza; Tom Taylor; Ahmed Hagag; Sophie Riedl; Julia Mai; Daniel Rueckert; Hrvoje Bogunovic; Hendrik P Scholl; Ursula Schmidt-Erfurth; Lars Fritsche; Andrew Lotery; Sobha Sivaprasad

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):3264.

ARVO Annual Meeting Abstract June 2024

Real-world outcomes of a Ranibizumab biosimilar product (Ongavia) in neovascular age related macular degeneration (nAMD) patients switched from a reference Ranibizumab product (Lucentis)

Evangelia Chalkiadaki; Abu Karim; Ian Yeung; Georgios Koutsocheras; Sing Yue Sim; Bishwanath Pal; Sobha Sivaprasad; Luke Nicholson; Robin Hamilton

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):1944.

ARVO Annual Meeting Abstract June 2024

Real-World Assessment and Clinician Acceptance of AI in GA Measurement

Robert Slater; Shruti Chandra; Thomas Saunders; Roomasa Channa; Sobha Sivaprasad; Barbara A Blodi; Rick Voland; Amitha Domalpally

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):2359.

ARVO Annual Meeting Abstract June 2024

Quantifying photoreceptor health using automated normalised ellipsoid zone reflectivity in Age-Related Macular Degeneration

Edward Adams; Sobha Sivaprasad; Shruti Chandra

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):2282.

ARVO Annual Meeting Abstract June 2024

BCVA gains with aflibercept 8 mg maintained through Week 96 in PULSAR with extended treatment intervals in patients with nAMD

Sobha Sivaprasad; Jean-Francois Korobelnik

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):2115.

ARVO Annual Meeting Abstract June 2024

Assessment of artificial intelligence to determine referral pathways in a real-world population of the English Diabetic Eye Screening Programme (DESP)

Tunde Peto; Giulia Bignami; Anne-Marie Cairns; Ashleigh Kernohan; Philip Kirby; Sobha Sivaprasad; Dominik Temmesfeld; Luke Vale; Sunny Virmani; Lin Yang; Xiang Yin; Xiang Ji; Luke Nicholson

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):4921.

ARVO Annual Meeting Abstract June 2024

Impact of Disease Activity Criteria on Extending Injection Intervals in Real-World Patients with Neovascular Age-related Macular Degeneration: A Moorfields Analysis

Bhairavi Bhatia; Sing Yue Sim; Evangelia Chalkiadaki; Georgios Koutsocheras; Luke Nicholson; Senthil Sevlam; Pearse Andrew Keane; Bishwanath Pal; Sobha Sivaprasad; Robin Hamilton; Praveen J Patel

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):4902.

ARVO Annual Meeting Abstract June 2024

Real-world treatment patterns and outcomes in the first 6 and 12 months of faricimab use among eyes with diabetic macular edema (DME) in the UK: FARWIDE-DME

Rhianon Reynolds; Tunde Peto; Clare C Bailey; Louise Downey; Christine Kiire; Ian Pearce; Sobha Sivaprasad; Gloria Chi; Natalee James; Alice Rothwell; Neil Shah; Amanda Downey; Melanie Dodds; Parul Dayal

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):6237.

ARVO Annual Meeting Abstract June 2024

Outcomes of the HORNBILL study: a Phase I/IIa trial investigating BI 764524 in patients with diabetic macular ischemia

Quan Dong Nguyen; Chirag Jhaveri; Maged S Habib; Elizabeth Pearce; Khaled Nassar; Bartlomiej Krawczyk; Martin Gliem; Sobha Sivaprasad

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):959.

1 2 3 4 5

Next 20 Results »

NARROW

Content Type

Journal

Article Type

Topics

Tags

Specify Date Range

Evaluating the distribution of fundus autofluorescence phenotypes in a large, European intermediate AMD cohort and describing a novel phenotype (A PINNACLE Study Report)

Evaluating Retinal Sensitivity Losses on Microperimetry in Diabetic Macular Ischemia – One Year Result

Intersession repeatability and annual changes in optical coherence tomography angiography (OCTA) metrics and visual function in diabetic macular ischaemia

Prevalence and Risk Factors of Type 2 Diabetes Mellitus and Diabetic Retinopathy among People Living with HIV in South India

An interpretable deep learning model for detection of referable/non-referable diabetic retinopathy: a retrospective, multicenter study

Patient-tailored Microperimetry Grids for Focal Lesions in Intermediate AMD: A PINNACLE Study Report

Promoting ophthalmic research in underserved communities.

Real-world outcomes of faricimab injections in treatment-naïve neovascular age-related macular degeneration (nAMD) patients: The Moorfields Experience

A 96-week PULSAR subgroup analysis: Similar visual and anatomic improvements with aflibercept 8 mg every 12 weeks or longer and 2 mg every 8 weeks, as defined by baseline BCVA, CRT, CNV type, and race

Validation of polygenic risk score in age-related macular degeneration prognosis: a pilot study

Comparative analysis of anatomical and visual parameters in treatment-resistant neovascular age related macular degeneration (nAMD) patients pre- and post-switch to faricimab: A Moorfields Analysis

Using adaptive optics to assess hyporeflective clumps as a biomarker for progression to cRORA in the PINNACLE study

Real-world outcomes of a Ranibizumab biosimilar product (Ongavia) in neovascular age related macular degeneration (nAMD) patients switched from a reference Ranibizumab product (Lucentis)

Real-World Assessment and Clinician Acceptance of AI in GA Measurement

Quantifying photoreceptor health using automated normalised ellipsoid zone reflectivity in Age-Related Macular Degeneration

BCVA gains with aflibercept 8 mg maintained through Week 96 in PULSAR with extended treatment intervals in patients with nAMD

Assessment of artificial intelligence to determine referral pathways in a real-world population of the English Diabetic Eye Screening Programme (DESP)

Impact of Disease Activity Criteria on Extending Injection Intervals in Real-World Patients with Neovascular Age-related Macular Degeneration: A Moorfields Analysis

Real-world treatment patterns and outcomes in the first 6 and 12 months of faricimab use among eyes with diabetic macular edema (DME) in the UK: FARWIDE-DME

Outcomes of the HORNBILL study: a Phase I/IIa trial investigating BI 764524 in patients with diabetic macular ischemia

To View More...

You must be signed into an individual account to use this feature.